0001225208-22-008089.txt : 20220614 0001225208-22-008089.hdr.sgml : 20220614 20220614182839 ACCESSION NUMBER: 0001225208-22-008089 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220610 FILED AS OF DATE: 20220614 DATE AS OF CHANGE: 20220614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wengel Kathryn E CENTRAL INDEX KEY: 0001745955 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 221016120 MAIL ADDRESS: STREET 1: JOHNSON & JOHNSON STREET 2: ONE JOHNSON & JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0101 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 4 1 doc4.xml X0306 4 2022-06-10 0000200406 JOHNSON & JOHNSON JNJ 0001745955 Wengel Kathryn E ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 1 EVP, Chief GSC Officer Common Stock 2022-06-10 4 M 0 40000.0000 72.5400 A 111310.8735 D Common Stock 2022-06-10 4 S 0 100.0000 173.0010 D 111210.8735 D Common Stock 2022-06-10 4 S 0 174.0000 173.0010 D 111036.8735 D Common Stock 2022-06-10 4 S 0 6600.0000 173.0010 D 104436.8735 D Common Stock 2022-06-10 4 S 0 33126.0000 173.0010 D 71310.8735 D Common Stock 50.0000 I By 401k Common Stock 281.0000 I By ESOP Employee Stock Options (Right to Buy) 72.5400 2022-06-10 4 M 0 40000.0000 0.0000 D 2016-01-17 2023-01-13 Common Stock 40000.0000 16410.0000 D This transaction was executed in multiple trades at prices ranging from 173.00 to 173.02 . The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2022) Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (5/31/2022) Raavi K. Deol, as attorney-in-fact for Kathryn E. Wengel 2022-06-14